Nanjing, China · Founded 2012 · Privately Held (backing)
Manufacturer of in vitro diagnostic kits designed for early detection of liver cancer in patients with chronic hepatitis B and cirrhosis. SYSDIAGNO is based in Nanjing, China and was founded in 2012. It has raised $14.8 million.
Last price · $/share
—
Implied valuation
—
Total raised
$14.8M
Last round
—
How much has SYSDIAGNO raised?
$14.8Macross 0 recorded rounds
Free account
More of SYSDIAGNO with a free account
·Watch SYSDIAGNO: the Monday email on marks, rounds and moves